| Pack |
|---|
| 60 capsule |
| 30 capsule |
| 20 capsule |
| Pack |
|---|
| 30 capsule |
| 20 capsule |
| 60 capsule |
| Pack |
|---|
| 28 tablet |
| 30 tablet |
| 9 tablet |
| Pack |
|---|
| 28 tablet |
| 30 tablet |
| 20 tablet |
| Pack |
|---|
| 56 capsule |
| Pack |
|---|
| 28 capsule |
| Pack |
|---|
| 10 suppository |
| Pack |
|---|
| 10 suppository |
| Pack |
|---|
| 10 suppository |
| Pack |
|---|
| 10 suppository |
| Pack |
|---|
| 10 ampoule |
| Pack |
|---|
| 28 tablet |
| Pack |
|---|
| 28 tablet |
| 30 tablet |
| 20 tablet |
| 40 tablet |
| Pack |
|---|
| 28 tablet |
| 30 tablet |
| 20 tablet |
| 40 tablet |
| 5 tablet |
| Pack |
|---|
| 7 tablet |
| 28 tablet |
| 30 tablet |
| 5 tablet |
Naproxen (≤1000 mg per day) and low-dose ibuprofen (≤1200 mg per day) are considered to have the most favourable thrombotic cardiovascular safety profiles of all NSAIDs.
| Pack |
|---|
| 96 tablet |
| 500 tablet |
| 12 tablet |
| 100 tablet |
| 24 tablet |
| 48 tablet |
| 84 tablet |
| 16 tablet |
| 8 tablet |
| Pack |
|---|
| 24 tablet |
| 250 tablet |
| 90 tablet |
| 100 tablet |
| 96 tablet |
| 48 tablet |
| 12 tablet |
| 84 tablet |
| 16 tablet |
| 60 tablet |
| Pack |
|---|
| 100 ml |
| 150 ml |
| 500 ml |
| 200 ml |
| Pack |
|---|
| 30 gram |
| 35 gram |
| 100 gram |
| 50 gram |
| 40 gram |
| Pack |
|---|
| 28 capsule |
| 90 capsule |
| 500 capsule |
| 84 capsule |
| Pack |
|---|
| 28 capsule |
| 100 capsule |
| 90 capsule |
| 84 capsule |
| Pack |
|---|
| 10 suppository |
Ibuprofen or naproxen can also be prescribed and are equally effective for the treatment of dysmenorrhea and menorrhagia. Naproxen and ibuprofen are more cost effective options compared to mefenamic acid.
| Pack |
|---|
| 500 capsule |
| 84 capsule |
| 100 capsule |
| Pack |
|---|
| 100 tablet |
| 84 tablet |
| 28 tablet |
| 30 tablet |
| Pack |
|---|
| 30 tablet |
| 60 tablet |
| 28 tablet |
| 20 tablet |
| 14 tablet |
| Pack |
|---|
| 30 tablet |
| 20 tablet |
| 60 tablet |
Naproxen (≤1000 mg per day) and low-dose ibuprofen (≤1200 mg per day) are considered to have the most favourable thrombotic cardiovascular safety profiles of all NSAIDs
| Pack |
|---|
| 250 tablet |
| 56 tablet |
| 28 tablet |
| 84 tablet |
| Pack |
|---|
| 60 tablet |
| 100 tablet |
| 56 tablet |
| 28 tablet |
| 500 tablet |
| 250 tablet |